The Chemours Company (CC) Return on equity 2016–2025
The Chemours Company (CC) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-154.4%FY2025 · since FY2016: 7.0% → -154.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -154.4% | -166.5 pp |
| FY2024 | 12.1% | +47.2 pp |
| FY2023 | -35.1% | -87.3 pp |
| FY2022 | 52.2% | -4.0 pp |
| FY2021 | 56.2% | +29.3 pp |
| FY2020 | 26.9% | +34.5 pp |
| FY2019 | -7.5% | -105.7 pp |
| FY2018 | 98.1% | +11.4 pp |
| FY2017 | 86.7% | +79.7 pp |
| FY2016 | 7.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice